CAMP and breast carcinoma: PAICS, a key enzyme for de novo purine synthesis, activates the cAmp/PKA signaling pathway, promotes mTOR activity, activates estrogen receptor alpha, and enhances estrogen dependence and tamoxifen resistance in breast cancer [39].